Literature DB >> 28431769

Trends in admissions for chest pain after the introduction of high-sensitivity cardiac troponin T.

Nadia Bandstein1, Rickard Ljung2, Magnus Lundbäck3, Magnus Johansson4, Martin J Holzmann5.   

Abstract

BACKGROUND: The aim was to describe temporal trends in admission rates for chest pain and patient outcomes after the clinical introduction of the high-sensitivity cardiac troponin T (hs-cTnT) assay.
METHODS: We included all patients aged >25years presenting with chest pain to the emergency department (ED) at our hospital during 2011-2014. For each year, rates of admissions, coronary angiographies, and revascularizations were determined. After adjustment for confounders, hazard ratios (HR) with 95% confidence intervals (CI) were calculated for mortality or major adverse cardiac events (MACE) within 1year of the ED visit per year, using 2011 as referent.
RESULTS: In total, 15,472 chest pain patients were accountable for 18,237 visits to the ED. The chest pain admission rate in 2011 was 44%; 2012, 39%; 2013, 33%; and 2014, 28%, with an overall decrease in 36%. Coronary angiographies within 1year of the ED visit increased from 6.8% in 2011 to 9.6% in 2013, but the proportion of revascularizations was virtually unchanged. The risk of death within 1year of the visit increased by 51% (HR 1.51, 95% CI, 1.18-1.92) in 2014, compared with 2011. Only non-cardiovascular mortality was significantly increased (HR 1.85, 95% CI, 1.34-2.55), with no increase in MACE.
CONCLUSION: Admissions for chest pain were reduced by 36% the first 4years of hs-cTnT use. We observed no increase in MACE, but all-cause mortality increased significantly for non-cardiovascular causes only which was paralleled by a significant increase in the use of coronary angiographies.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chest pain; Emergency department; High-sensitivity cardiac troponin T; Hospital admission; Outcomes

Mesh:

Substances:

Year:  2017        PMID: 28431769     DOI: 10.1016/j.ijcard.2017.04.028

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Implementation of High-Sensitivity Cardiac Troponin: Challenges From the International Experience.

Authors:  Stacey J Howell; Ezra A Amsterdam; Bryn E Mumma; Javier E López; Nam K Tran
Journal:  Crit Pathw Cardiol       Date:  2018-12

2.  Distribution of contemporary sensitivity troponin in the emergency department and relationship to 30-day mortality: The CHARIOT-ED substudy.

Authors:  Jonathan Hinton; Mark Mariathas; Lavinia Gabara; Zoe Nicholas; Rick Allan; Sanjay Ramamoorthy; Mamas A Mamas; Michael Mahmoudi; Paul Cook; Nick Curzen
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

3.  Diagnostic Reclassification by a High-Sensitivity Cardiac Troponin Assay.

Authors:  Bryn E Mumma; Scott D Casey; Robert K Dang; Michelle K Polen; Jasmanpreet C Kaur; John Rodrigo; Daniel J Tancredi; Robert A Narverud; Ezra A Amsterdam; Nam Tran
Journal:  Ann Emerg Med       Date:  2020-08-15       Impact factor: 5.721

4.  RAPID-CPU: a prospective study on implementation of the ESC 0/1-hour algorithm and safety of discharge after rule-out of myocardial infarction.

Authors:  Kiril M Stoyanov; Hauke Hund; Moritz Biener; Jochen Gandowitz; Christoph Riedle; Julia Löhr; Matthias Mueller-Hennessen; Mehrshad Vafaie; Hugo A Katus; Evangelos Giannitsis
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2019-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.